Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report

Peer Review reports

Original Submission
11 Sep 2017	Submitted	Original manuscript
1 Oct 2017	Reviewed	Reviewer Report - Bijin Thajudeen
10 Oct 2017	Reviewed	Reviewer Report - Anushree C Shirali
25 Nov 2017	Author responded	Author comments - Ryo Koda
Resubmission - Version 2
25 Nov 2017	Submitted	Manuscript version 2
10 Dec 2017	Reviewed	Reviewer Report - Bijin Thajudeen
15 Feb 2018	Author responded	Author comments - Ryo Koda
Resubmission - Version 3
15 Feb 2018	Submitted	Manuscript version 3
Publishing
20 Feb 2018	Editorially accepted
27 Feb 2018	Article published	10.1186/s12882-018-0848-y

Back to article page